Követés
Thomas T. Huynh
Thomas T. Huynh
E-mail megerősítve itt: dal.ca
Cím
Hivatkozott rá
Hivatkozott rá
Év
ALDH1A3-regulated long non-coding RNA NRAD1 is a potential novel target for triple-negative breast tumors and cancer stem cells
D Vidovic, TT Huynh, P Konda, C Dean, BM Cruickshank, M Sultan, ...
Cell Death & Differentiation 27 (1), 363-378, 2020
902020
Epigenetic Silencing of TAP1 in Aldefluor+ Breast Cancer Stem Cells Contributes to Their Enhanced Immune Evasion
M Sultan, D Vidovic, AS Paine, TT Huynh, KM Coyle, ML Thomas, ...
Stem Cells 36 (5), 641-654, 2018
502018
Retinoic acid and arsenic trioxide induce lasting differentiation and demethylation of target genes in APL cells
TT Huynh, M Sultan, D Vidovic, CA Dean, BM Cruickshank, K Lee, ...
Scientific reports 9 (1), 9414, 2019
362019
An in vivo genome‐wide shRNA screen identifies BCL6 as a targetable biomarker of paclitaxel resistance in breast cancer
M Sultan, JT Nearing, JM Brown, TT Huynh, BM Cruickshank, ...
Molecular Oncology 15 (8), 2046-2064, 2021
62021
An in vivo genome-wide RNAi screen identifies novel mediators of paclitaxel response in breast cancer
M Sultan, BM Cruickshank, T Huynh, E Lamoureux, D Vidovic, ML Dahn, ...
Annals of Oncology 30, iii23-iii24, 2019
12019
ALL-TRANS RETINOIC ACID AND ARSENIC TRIOXIDE INDUCE LASTING DIFFERENTIATION AND DEMETHYLATION OF TARGET GENES IN ACUTE PROMYELOCYTIC LEUKEMIA
T Huynh
2019
PO-372 Investigating the epigenetic changes underlying combination treatment of acute promyelocytic leukaemia with all-trans retinoic acid and arsenic trioxide
T Huynh, D Vidovic, C Dean, K Lee, I Weaver, P Marcato
ESMO Open 3, A167, 2018
2018
Abstract B26: Identification of genes that predict response to paclitaxel in breast cancer using an in vivo genome-wide knockdown screen
M Sultan, TT Huynh, ML Thomas, KM Coyle, CA Giacomantonio, ...
Molecular Cancer Research 14 (2_Supplement), B26-B26, 2016
2016
A rendszer jelenleg nem tudja elvégezni a műveletet. Próbálkozzon újra később.
Cikkek 1–8